Werkgroep Cardiologische centra Nederland English

CLEAR Harmony 1002-040 (Klaar)

A Randomized, Double-blind, Placebo-controlled, Multicenter Long-term Safety and Tolerability Study of ETC-1002 in Patients With Hyperlipidemia at High Cardiovascular Risk Who Are Not Adequately Controlled by Their Lipid-Modifying Therapy

Middel
ETC-1002
Populatie
secundaire preventie
Fase
III
Jaar aanvang
2015
Meer informatie
ClinicalTrials.gov

Studiedirecteur

dr. W.R.M. Hermans (Cardioloog)
Tilburg, ETZ Elisabeth